Market revenue in 2023 | USD 200.6 million |
Market revenue in 2030 | USD 268.2 million |
Growth rate | 4.2% (CAGR from 2023 to 2030) |
Largest segment | Tablets |
Fastest growing segment | Capsules |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tablets, Capsules, Powders, Granules |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 31.75% in 2023. Horizon Databook has segmented the Norway oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing R&D activities are expected to drive Norway's oral solid dosage contract manufacturing market. This is expected to boost its production capacity for tablets, propelling the demand for oral solid contract manufacturing to ensure the quality & compliance of the produced pharmaceuticals.
More extensive services offered by CMOs to scale up its production capacity and introduce new products, which is expected to increase the demand for oral solid dosage contract manufacturing in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway oral solid dosage contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Norway oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account